These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


892 related items for PubMed ID: 8711643

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
    Evans SA, Colville A, Evans AJ, Crisp AJ, Johnston ID.
    Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
    Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of Mycobacterium xenopi in human disease.
    Simor AE, Salit IE, Vellend H.
    Am Rev Respir Dis; 1984 Mar; 129(3):435-8. PubMed ID: 6703502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey].
    Albayrak N, Simşek H, Sezen F, Arslantürk A, Tarhan G, Ceyhan I.
    Mikrobiyol Bul; 2012 Oct; 46(4):560-7. PubMed ID: 23188570
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort.
    Zweijpfenning S, Kops S, Magis-Escurra C, Boeree MJ, van Ingen J, Hoefsloot W.
    Respir Med; 2017 Oct; 131():220-224. PubMed ID: 28947034
    [Abstract] [Full Text] [Related]

  • 13. The therapeutic approach to non-tuberculous mycobacterial infection of the lung.
    McGrath EE, Anderson PB.
    Pulm Pharmacol Ther; 2010 Oct; 23(5):389-96. PubMed ID: 20542128
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Davies BS, Roberts CH, Kaul S, Klein JL, Milburn HJ.
    Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
    [Abstract] [Full Text] [Related]

  • 17. Rifampin-resistant Mycobacterium kansasii.
    Wallace RJ, Dunbar D, Brown BA, Onyi G, Dunlap R, Ahn CH, Murphy DT.
    Clin Infect Dis; 1994 May; 18(5):736-43. PubMed ID: 8075262
    [Abstract] [Full Text] [Related]

  • 18. Profile of patients with pulmonary non-tuberculous mycobacterial disease mimicking pulmonary tuberculosis.
    Gomathy NS, Padmapriyadarsini C, Silambuchelvi K, Nabila A, Tamizhselvan M, Banurekha VV, Lavanya J, Chandrasekar C.
    Indian J Tuberc; 2019 Oct; 66(4):461-467. PubMed ID: 31813432
    [Abstract] [Full Text] [Related]

  • 19. [Distribution and drug resistance of nontuberculous Mycobacteria in Beijing].
    Zhang J, Su JR, Ding BC, Liu JW, Yi JL, Yang XY, Wang NH, Wang SM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar 12; 40(3):210-214. PubMed ID: 28297817
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 45.